FAM
AEGR

Fred Alger Management’s Aegerion Pharmaceuticals AEGR Stock Holding History

Fred Alger Management’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-201,433
Closed -$6.46M – 658
2014
Q2 		$6.46M Buy
201,433
+46,854
+30% +$1.74M 0.03% 335
2014
Q1 		$7.14M Sell
154,579
-27,126
-15% -$1.59M 0.04% 329
2013
Q4 		$12.9M Buy
181,705
+86,759
+91% +$6.63M 0.07% 270
2013
Q3 		$8.14M Sell
94,946
-15,021
-14% -$1.27M 0.05% 304
2013
Q2 		$6.96M Buy
+109,967
New +$5.84M 0.04% 322

Other funds holding AEGR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fred Alger Management's AEGR Position: Q3 2014 in Review

Fred Alger Management sold out of Aegerion Pharmaceuticals (AEGR) in Q3 2014, closing a stake of 201,433 shares — an estimated $6.46M sold.

Fred Alger Management first reported a position in AEGR in Q2 2013 and held it in 5 quarters. The position peaked at $12.9M in Q4 2013. 131 funds tracked by Wall St. Rank hold AEGR as of Q3 2014.

  • Fred Alger Management reported no remaining Aegerion Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • Fred Alger Management sold 201,433 Aegerion Pharmaceuticals shares in Q3 2014, an estimated $6.46M.
  • Fred Alger Management first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 5 quarters.
  • Fred Alger Management's Aegerion Pharmaceuticals position peaked at $12.9M in Q4 2013.
  • 131 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q3 2014.

Based on Fred Alger Management's 13F filing for Q3 2014, filed 14 Nov 2014.